General Information of the Compound
Compound ID
CP0538957
Compound Name
N-(1-(2-(azepan-1- yl)ethyl)-1H-pyrazolo[3,4- d]pyrimidin-4-yl)-4- fluorobenzamide citrate
    Show/Hide
Structure
Formula
C20H23FN6O
Molecular Weight
382.443
Canonical SMILES
Fc1ccc(cc1)C(=O)Nc1ncnc2n(CCN3CCCCCC3)ncc12
    Show/Hide
InChI
InChI=1S/C20H23FN6O/c21-16-7-5-15(6-8-16)20(28)25-18-17-13-24-27(19(17)23-14-22-18)12-11-26-9-3-1-2-4-10-26/h5-8,13-14H,1-4,9-12H2,(H,22,23,25,28)
    Show/Hide
InChIKey
YOAYREJMPDJKKK-UHFFFAOYSA-N
Physicochemical Property
logP
3.0937
Rotatable Bonds
5
Heavy Atom Count
28
Polar Areas
75.94
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71223232
ChEMBL ID
CHEMBL4286394
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01509, Sigma non-opioid intracellular receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 156 nM
   TI
   LI
   LO
   TS